These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice. Tovey E; Rampes H; Livingstone C J Psychopharmacol; 2005 Mar; 19(2):207-10. PubMed ID: 15728442 [TBL] [Abstract][Full Text] [Related]
3. Three potentially fatal adverse effects of psychotropic medications. Wren P; Frizzell LA; Keltner NL; Wright AV Perspect Psychiatr Care; 2003; 39(2):75-81. PubMed ID: 12894601 [No Abstract] [Full Text] [Related]
4. Treatment settings and metabolic monitoring for people experiencing first-episode psychosis. Batscha C; Schneiderhan ME; Kataria Y; Rosen C; Marvin RW J Psychosoc Nurs Ment Health Serv; 2010 Sep; 48(9):44-9. PubMed ID: 20795590 [TBL] [Abstract][Full Text] [Related]
5. [Time for every psychiatric clinic to take full responsibility for metabolic side effects of antipsychotic drugs!]. Gothefors D; Jarbin H Lakartidningen; 2010 Mar 24-30; 107(12):845-6. PubMed ID: 20432835 [No Abstract] [Full Text] [Related]
6. Hypoglycemia in hospitalized adults. Anthony M Medsurg Nurs; 2008 Feb; 17(1):31-4, 40. PubMed ID: 18429538 [TBL] [Abstract][Full Text] [Related]
7. An evaluation of monitoring practices in patients on second generation antipsychotics. Nguyen D; Brakoulias V; Boyce P Australas Psychiatry; 2009 Aug; 17(4):295-9. PubMed ID: 19585292 [TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics in the elderly with Parkinson disease and the "black box" warning. Rosenkilde CE Neurology; 2007 Apr; 68(16):1325; author reply 1325-6. PubMed ID: 17438231 [No Abstract] [Full Text] [Related]
9. Consensus development conference on antipsychotic drugs and obesity and diabetes. ; ; ; Obes Res; 2004 Feb; 12(2):362-8. PubMed ID: 14981231 [No Abstract] [Full Text] [Related]
10. E-FALCONS. A mnemonic for monitoring the prescribing of atypical antipsychotics. Gill T; Khouzam HR; Tan DT Geriatrics; 2004 Aug; 59(8):41-2, 45. PubMed ID: 15332416 [No Abstract] [Full Text] [Related]
11. Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients. Correll CU Int Rev Psychiatry; 2008 Apr; 20(2):195-201. PubMed ID: 18386212 [TBL] [Abstract][Full Text] [Related]
12. Metabolic abnormalities associated with atypical antipsychotics: a case report and alert. Yamauchi T; Tice A Hawaii Med J; 2007 Jan; 66(1):12-3. PubMed ID: 17381036 [TBL] [Abstract][Full Text] [Related]
13. Monitoring adverse drug reactions: scales, profiles, and checklists. Jordan S; Knight J; Pointon D Int Nurs Rev; 2004 Dec; 51(4):208-21. PubMed ID: 15530161 [TBL] [Abstract][Full Text] [Related]
14. Incorporating clinical monitoring into electronic orders for antipsychotics. Roche-Desilets J; Fuller MA; Konicki PE Psychiatr Serv; 2004 Apr; 55(4):455. PubMed ID: 15067165 [No Abstract] [Full Text] [Related]
15. [Diabetes in treatment with antipsychotic drugs: who is at risk]]. Deuschle M MMW Fortschr Med; 2005 Dec; 147(51-52):34. PubMed ID: 16402705 [No Abstract] [Full Text] [Related]
16. Antipsychotic medications and seizures. Marks RC; Luchins DJ Psychiatr Med; 1991; 9(1):37-52. PubMed ID: 1673258 [TBL] [Abstract][Full Text] [Related]
17. Benefits and methods of achieving strict glycemic control in the ICU. Roberts SR; Hamedani B Crit Care Nurs Clin North Am; 2004 Dec; 16(4):537-45. PubMed ID: 15571942 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of diabetes mellitus in patients receiving depot neuroleptics or clozapine. Miller MJ; Molla PM Arch Psychiatr Nurs; 2005 Feb; 19(1):30-4. PubMed ID: 15765369 [TBL] [Abstract][Full Text] [Related]
19. Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring. De Hert M; van Eyck D; De Nayer A Int Clin Psychopharmacol; 2006 Mar; 21 Suppl 2():S11-5. PubMed ID: 16601508 [TBL] [Abstract][Full Text] [Related]
20. [Increased risk of cardiovascular diseases and diabetes in mentally ill persons. Life style is a contributing factor]. Attvall S; Eliasson B; Nilsson P Lakartidningen; 2003 Jul; 100(28-29):2353-5. PubMed ID: 12899026 [No Abstract] [Full Text] [Related] [Next] [New Search]